title: Clinical consequences of human herpesvirus-6 DNAemia in peripheral blood in pediatric liver transplant recipients.
abstract: The significance of HHV6 DNAemia after solid organ transplantation has not been fully determined. Our objectives were to determine the prevalence of HHV6 DNAemia in pediatric liver transplant recipients and to describe the associated clinical characteristics and outcomes. This was a retrospective case-control study. Eligible liver transplant patients aged ≤ 18 yr with HHV6 DNAemia were matched with two subjects without HHV6 DNAemia. Matching was by age ± 6 months. Among 154 subjects, 25 patients (16%) had HHV6 DNAemia detected by PCR in whole blood or plasma (M:F ratio = 0.9:1). While 28% of subjects with DNAemia (7/25) had symptoms consistent with HHV6 infection, active infection was detected in only four subjects (2.6% of liver transplant patients). The major symptoms/signs were fever, vomiting, lethargy, splenomegaly, bone marrow suppression, and elevated transaminases. The prevalence of DNAemia due to other herpesviruses in cases vs. controls was EBV 56% vs. 60%, CMV 12% vs. 12%, HHV7 20% vs. 12%; p value is not significant for all pairwise comparisons. HHV6 DNAemia in pediatric liver transplant patients is not an uncommon entity. While the clinical relevance is still not entirely established, active HHV6 infection and attributable symptoms are relatively rare.
authors.affiliation: Division of Infectious Diseases, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
authors.forename: Tariq
authors.initials: T
authors.lastname: Al Fawaz
authors.forename: Vicky
authors.initials: V
authors.lastname: Ng
authors.forename: Susan E
authors.initials: SE
authors.lastname: Richardson
authors.forename: Michelle
authors.initials: M
authors.lastname: Barton
authors.forename: Upton
authors.initials: U
authors.lastname: Allen
mesh_terms: D000293:Adolescent; D000998:Antiviral Agents / Q000737:chemistry; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D015897:Comorbidity; D004279:DNA, Viral / Q000097:blood*; D005260:Female; D006084:Graft Rejection; D015654:Herpesvirus 6, Human; D006801:Humans; D007223:Infant; D017093:Liver Failure / Q000150:complications / Q000628:therapy*; D016031:Liver Transplantation; D008297:Male; D015995:Prevalence; D012189:Retrospective Studies; D016896:Treatment Outcome; D014777:Virus Diseases / Q000097:blood* / Q000150:complications
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral
keywords: HHV6; herpesvirus; liver transplant; pediatric transplantation